Management of Cutaneous Angiosarcoma: an Update Review.

Bi, Siwei; Zhong, Ai; Yin, Xiya; Li, Jingyi; Cen, Ying; Chen, Junjie

Bi, Siwei; Zhong, Ai; Yin, Xiya; Li, Jingyi; Cen, Ying; Chen, Junjie.

Afiliação

Bi S; Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhong A; Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yin X; West China School of Medicine, Sichuan University, Chengdu, 610041, China.
Li J; West China School of Medicine, Sichuan University, Chengdu, 610041, China.
Cen Y; Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. cenying0141@163.com.
Chen J; Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. cjjemail@163.com.

Curr Treat Options Oncol ; 23(2): 137-154, 2022 02.

Article em En | MEDLINE | ID: mdl-35182299

Assuntos

Hemangiossarcoma; Neoplasias Cutâneas; Quimiorradioterapia; Hemangiossarcoma/diagnóstico; Hemangiossarcoma/etiologia; Hemangiossarcoma/terapia; Humanos; Terapia Neoadjuvante; Paclitaxel/uso terapêutico; Neoplasias Cutâneas/diagnóstico; Neoplasias Cutâneas/etiologia; Neoplasias Cutâneas/terapia

Palavras-chave

Chemotherapy; Cutaneous angiosarcoma; Immunotherapy; Radiotherapy; Surgery; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Hemangiossarcoma Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Curr Treat Options Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google